Shenzhen UTIMES Intelligent Equipment (688638.SH) plans to launch a restricted stock incentive plan for 2026.
Yuchen Intelligent (688638.SH) disclosed the 2026 Restricted Stock Incentive Plan (draft), with a proposed grant of 1,045,317 shares of restricted stock, accounting for 1.87% of the total equity of the company at the time of the announcement of the incentive plan draft. This incentive plan is a one-time grant with no reserved rights. The proposed number of incentive recipients does not exceed 91 people, and the grant price is 20.42 yuan per share.
Shenzhen UTIMES Intelligent Equipment (688638.SH) disclosed the 2026 Restricted Stock Incentive Plan (draft), with a proposed grant of 1,045,317 shares of restricted stock, accounting for 1.87% of the total share capital of the company at the time of the announcement of the incentive plan draft. This incentive plan is a one-time grant with no reserved rights. The intended recipients of the incentive plan will not exceed 91 individuals, and the grant price is 20.42 yuan per share.
Related Articles

CHINA INFO TECH (08178) announced its annual performance, with a net loss attributable to shareholders of HK$99.459 million for the year, representing a 164.28% increase compared to the previous year.

BRIGHTSTAR TECH (08446) announces its annual performance for 2025, with a net profit attributable to shareholders of HK$25,949,000, a decrease of 38.7% compared to the previous year.

Ming Liang Holdings (08152) announced its 2025 performance, with a profit attributable to equity holders of HK$9.426 million, turning losses into profits year on year.
CHINA INFO TECH (08178) announced its annual performance, with a net loss attributable to shareholders of HK$99.459 million for the year, representing a 164.28% increase compared to the previous year.

BRIGHTSTAR TECH (08446) announces its annual performance for 2025, with a net profit attributable to shareholders of HK$25,949,000, a decrease of 38.7% compared to the previous year.

Ming Liang Holdings (08152) announced its 2025 performance, with a profit attributable to equity holders of HK$9.426 million, turning losses into profits year on year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


